Mri and targeted biopsy essential tools for an accurate diagnosis and treatment decision making in prostate cancer

Suraj Samtani, Mauricio Burotto, Juan Carlos Roman, Daniela Cortes-Herrera, Annerleim Walton-Diaz

Research output: Contribution to journalReview articlepeer-review

Abstract

Prostate cancer (PCa) is one of the most frequent causes of cancer death worldwide. Historically, diagnosis was based on physical examination, transrectal (TRUS) images, and TRUS biopsy resulting in overdiagnosis and overtreatment. Recently magnetic resonance imaging (MRI) has been identified as an evolving tool in terms of diagnosis, staging, treatment decision, and follow-up. In this review we provide the key studies and concepts of MRI as a promising tool in the diagnosis and management of prostate cancer in the general population and in challenging scenarios, such as anteriorly located lesions, enlarged prostates determining extracapsular extension and seminal vesicle invasion, and prior negative biopsy and the future role of MRI in association with artificial intelligence (AI).

Original languageEnglish
Article number1551
JournalDiagnostics
Volume11
Issue number9
DOIs
StatePublished - Sep 2021

Bibliographical note

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.

Keywords

  • Active surveillance
  • Artificial intelligence
  • Diagnosis
  • MRI
  • Prostate cancer

Fingerprint

Dive into the research topics of 'Mri and targeted biopsy essential tools for an accurate diagnosis and treatment decision making in prostate cancer'. Together they form a unique fingerprint.

Cite this